Rank | Gene Set | Z-score |
---|---|---|
1 | sulfation (GO:0051923) | 5.63475409 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.26753949 |
3 | L-phenylalanine catabolic process (GO:0006559) | 5.26753949 |
4 | behavioral response to nicotine (GO:0035095) | 5.22805267 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.02968104 |
6 | L-phenylalanine metabolic process (GO:0006558) | 5.02968104 |
7 | cellular response to ATP (GO:0071318) | 4.87539630 |
8 | regulation of skeletal muscle contraction (GO:0014819) | 4.69017607 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.63463300 |
10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.46627296 |
11 | aromatic amino acid family catabolic process (GO:0009074) | 4.46160848 |
12 | detection of light stimulus involved in visual perception (GO:0050908) | 4.35450927 |
13 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.35450927 |
14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.30476619 |
15 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.30476619 |
16 | NADH dehydrogenase complex assembly (GO:0010257) | 4.30476619 |
17 | kynurenine metabolic process (GO:0070189) | 4.03130539 |
18 | lysine catabolic process (GO:0006554) | 4.02276442 |
19 | lysine metabolic process (GO:0006553) | 4.02276442 |
20 | bile acid biosynthetic process (GO:0006699) | 3.94335831 |
21 | cellular ketone body metabolic process (GO:0046950) | 3.92980621 |
22 | glyoxylate metabolic process (GO:0046487) | 3.88411284 |
23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.88283806 |
24 | sulfur amino acid catabolic process (GO:0000098) | 3.85122966 |
25 | tryptophan catabolic process (GO:0006569) | 3.78209539 |
26 | indole-containing compound catabolic process (GO:0042436) | 3.78209539 |
27 | indolalkylamine catabolic process (GO:0046218) | 3.78209539 |
28 | cellular response to exogenous dsRNA (GO:0071360) | 3.78045754 |
29 | positive regulation of defense response to virus by host (GO:0002230) | 3.73104299 |
30 | high-density lipoprotein particle remodeling (GO:0034375) | 3.72841002 |
31 | glutamate metabolic process (GO:0006536) | 3.70311110 |
32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68940476 |
33 | protein complex biogenesis (GO:0070271) | 3.64414181 |
34 | cysteine metabolic process (GO:0006534) | 3.63719912 |
35 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.61538655 |
36 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.60843379 |
37 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.60843379 |
38 | short-chain fatty acid metabolic process (GO:0046459) | 3.60154434 |
39 | 2-oxoglutarate metabolic process (GO:0006103) | 3.59808275 |
40 | regulation of triglyceride catabolic process (GO:0010896) | 3.56206420 |
41 | amino-acid betaine metabolic process (GO:0006577) | 3.55248833 |
42 | urea cycle (GO:0000050) | 3.54485072 |
43 | urea metabolic process (GO:0019627) | 3.54485072 |
44 | tryptophan metabolic process (GO:0006568) | 3.51610080 |
45 | negative regulation of mast cell activation (GO:0033004) | 3.51336244 |
46 | positive regulation of digestive system process (GO:0060456) | 3.50126736 |
47 | aspartate family amino acid catabolic process (GO:0009068) | 3.49006521 |
48 | bile acid metabolic process (GO:0008206) | 3.42693751 |
49 | alpha-amino acid catabolic process (GO:1901606) | 3.41781661 |
50 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.40493002 |
51 | ketone body metabolic process (GO:1902224) | 3.40418638 |
52 | mitotic cell cycle arrest (GO:0071850) | 3.40079581 |
53 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.39806018 |
54 | protein carboxylation (GO:0018214) | 3.39806018 |
55 | reverse cholesterol transport (GO:0043691) | 3.39627189 |
56 | regulation of cholesterol esterification (GO:0010872) | 3.38883446 |
57 | regulation of bile acid biosynthetic process (GO:0070857) | 3.36812472 |
58 | negative regulation of fibrinolysis (GO:0051918) | 3.34268473 |
59 | protein import into peroxisome matrix (GO:0016558) | 3.33962360 |
60 | serine family amino acid catabolic process (GO:0009071) | 3.33187314 |
61 | acylglycerol homeostasis (GO:0055090) | 3.32255166 |
62 | triglyceride homeostasis (GO:0070328) | 3.32255166 |
63 | DNA deamination (GO:0045006) | 3.31566802 |
64 | regulation of fibrinolysis (GO:0051917) | 3.31524739 |
65 | fatty acid beta-oxidation (GO:0006635) | 3.30200283 |
66 | regulation of cholesterol homeostasis (GO:2000188) | 3.29538913 |
67 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.28982808 |
68 | cellular amino acid catabolic process (GO:0009063) | 3.28430803 |
69 | nitrogen cycle metabolic process (GO:0071941) | 3.27371891 |
70 | cellular modified amino acid catabolic process (GO:0042219) | 3.26036131 |
71 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.25833311 |
72 | ethanol oxidation (GO:0006069) | 3.25720409 |
73 | regulation of synapse structural plasticity (GO:0051823) | 3.25696222 |
74 | fatty acid transmembrane transport (GO:1902001) | 3.24452089 |
75 | dicarboxylic acid catabolic process (GO:0043649) | 3.24404263 |
76 | macromolecular complex remodeling (GO:0034367) | 3.22683056 |
77 | plasma lipoprotein particle remodeling (GO:0034369) | 3.22683056 |
78 | protein-lipid complex remodeling (GO:0034368) | 3.22683056 |
79 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.20951390 |
80 | drug catabolic process (GO:0042737) | 3.20669900 |
81 | fatty acid oxidation (GO:0019395) | 3.17884223 |
82 | tyrosine metabolic process (GO:0006570) | 3.17870542 |
83 | complement activation, alternative pathway (GO:0006957) | 3.17151670 |
84 | negative regulation of sterol transport (GO:0032372) | 3.15886300 |
85 | negative regulation of cholesterol transport (GO:0032375) | 3.15886300 |
86 | phospholipid efflux (GO:0033700) | 3.15566160 |
87 | aromatic amino acid family metabolic process (GO:0009072) | 3.14869682 |
88 | lipid oxidation (GO:0034440) | 3.14777056 |
89 | monocarboxylic acid catabolic process (GO:0072329) | 3.13271784 |
90 | regulation of protein activation cascade (GO:2000257) | 3.12770526 |
91 | fatty acid catabolic process (GO:0009062) | 3.11719106 |
92 | coenzyme catabolic process (GO:0009109) | 3.11148523 |
93 | acetyl-CoA metabolic process (GO:0006084) | 3.10264897 |
94 | carnitine shuttle (GO:0006853) | 3.08952709 |
95 | homocysteine metabolic process (GO:0050667) | 3.08742437 |
96 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.04788968 |
97 | flavonoid metabolic process (GO:0009812) | 3.03659864 |
98 | positive regulation of lipid catabolic process (GO:0050996) | 3.02813932 |
99 | negative regulation of lipase activity (GO:0060192) | 3.02745304 |
100 | plasma lipoprotein particle clearance (GO:0034381) | 3.02628158 |
101 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.01228562 |
102 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.00733175 |
103 | organic acid catabolic process (GO:0016054) | 2.99991501 |
104 | carboxylic acid catabolic process (GO:0046395) | 2.99991501 |
105 | GDP-mannose metabolic process (GO:0019673) | 2.99881178 |
106 | cellular glucuronidation (GO:0052695) | 2.99618769 |
107 | phospholipid homeostasis (GO:0055091) | 2.98799586 |
108 | regulation of somitogenesis (GO:0014807) | 2.98201152 |
109 | carnitine metabolic process (GO:0009437) | 2.98155628 |
110 | positive regulation of fatty acid oxidation (GO:0046321) | 2.95209692 |
111 | regulation of complement activation (GO:0030449) | 2.93637710 |
112 | L-fucose catabolic process (GO:0042355) | 2.92238620 |
113 | fucose catabolic process (GO:0019317) | 2.92238620 |
114 | L-fucose metabolic process (GO:0042354) | 2.92238620 |
115 | cytidine deamination (GO:0009972) | 2.91105585 |
116 | cytidine metabolic process (GO:0046087) | 2.91105585 |
117 | cytidine catabolic process (GO:0006216) | 2.91105585 |
118 | sterol catabolic process (GO:0016127) | 2.88866615 |
119 | cholesterol catabolic process (GO:0006707) | 2.88866615 |
120 | transepithelial transport (GO:0070633) | 2.86609823 |
121 | adaptation of signaling pathway (GO:0023058) | 2.85492103 |
122 | fatty acid homeostasis (GO:0055089) | 2.84224523 |
123 | succinate metabolic process (GO:0006105) | 2.84159561 |
124 | neuromuscular synaptic transmission (GO:0007274) | 2.83258065 |
125 | benzene-containing compound metabolic process (GO:0042537) | 2.82356771 |
126 | cholesterol efflux (GO:0033344) | 2.80657659 |
127 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.79891354 |
128 | exogenous drug catabolic process (GO:0042738) | 2.79482708 |
129 | low-density lipoprotein particle remodeling (GO:0034374) | 2.77332186 |
130 | cornea development in camera-type eye (GO:0061303) | 2.77173213 |
131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.76013085 |
132 | regulation of defense response to virus by host (GO:0050691) | 2.75861260 |
133 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.74680733 |
134 | urinary tract smooth muscle contraction (GO:0014848) | 2.73212447 |
135 | indolalkylamine metabolic process (GO:0006586) | 2.73131195 |
136 | valine metabolic process (GO:0006573) | 2.72301315 |
137 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.71238081 |
138 | bile acid and bile salt transport (GO:0015721) | 2.70401900 |
139 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.70271770 |
140 | regulation of cholesterol metabolic process (GO:0090181) | 2.68724840 |
141 | drug metabolic process (GO:0017144) | 2.67296670 |
142 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.67152384 |
143 | gamma-aminobutyric acid transport (GO:0015812) | 2.66272280 |
144 | activated T cell proliferation (GO:0050798) | 2.66188770 |
145 | dentate gyrus development (GO:0021542) | 2.65409244 |
146 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.64994010 |
147 | branched-chain amino acid catabolic process (GO:0009083) | 2.63992092 |
148 | positive regulation of protein homooligomerization (GO:0032464) | 2.63830027 |
149 | drug transmembrane transport (GO:0006855) | 2.62786977 |
150 | regulation of fatty acid oxidation (GO:0046320) | 2.62571049 |
151 | regulation of triglyceride metabolic process (GO:0090207) | 2.62000890 |
152 | protein polyglutamylation (GO:0018095) | 2.61825510 |
153 | parturition (GO:0007567) | 2.59474343 |
154 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.59142697 |
155 | negative regulation of multicellular organism growth (GO:0040015) | 2.59052795 |
156 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.58394943 |
157 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.57912854 |
158 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.54304476 |
159 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.53784036 |
160 | neuronal action potential (GO:0019228) | 2.50271360 |
161 | cell proliferation in forebrain (GO:0021846) | 2.49204250 |
162 | lens fiber cell differentiation (GO:0070306) | 2.48130602 |
163 | peristalsis (GO:0030432) | 2.47576492 |
164 | negative regulation of cell aging (GO:0090344) | 2.46030288 |
165 | regulation of synapse maturation (GO:0090128) | 2.45455829 |
166 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.42782249 |
167 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.41577960 |
168 | primary amino compound metabolic process (GO:1901160) | 2.40097727 |
169 | regulation of action potential (GO:0098900) | 2.39297806 |
170 | cellular anion homeostasis (GO:0030002) | 2.39052682 |
171 | regulation of cAMP-mediated signaling (GO:0043949) | 2.38464026 |
172 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.37963761 |
173 | sensory perception of taste (GO:0050909) | 2.37946728 |
174 | cardiovascular system development (GO:0072358) | 2.37877134 |
175 | photoreceptor cell development (GO:0042461) | 2.37583115 |
176 | interferon-gamma secretion (GO:0072643) | 2.36624567 |
177 | neuronal action potential propagation (GO:0019227) | 2.36009508 |
178 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.33960596 |
179 | pseudouridine synthesis (GO:0001522) | 2.32954097 |
180 | response to ATP (GO:0033198) | 2.32839814 |
181 | positive regulation of synapse maturation (GO:0090129) | 2.32778270 |
182 | replicative senescence (GO:0090399) | 2.32482350 |
183 | purinergic receptor signaling pathway (GO:0035587) | 2.31829127 |
184 | serotonin metabolic process (GO:0042428) | 2.31784583 |
185 | iron coordination entity transport (GO:1901678) | 2.31692729 |
186 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.31682411 |
187 | NAD biosynthetic process (GO:0009435) | 2.31051648 |
188 | mast cell degranulation (GO:0043303) | 2.29667445 |
189 | mast cell activation involved in immune response (GO:0002279) | 2.29667445 |
190 | response to misfolded protein (GO:0051788) | 2.28444929 |
191 | eye photoreceptor cell development (GO:0042462) | 2.28422089 |
192 | positive regulation of fatty acid transport (GO:2000193) | 2.26432336 |
193 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.25280060 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.65244734 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.95264661 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.90302728 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.17052649 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.13532631 |
6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.95097594 |
7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.62329935 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.50439891 |
9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.00859822 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.85494372 |
11 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.63642564 |
12 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29276604 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24583816 |
14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.96141011 |
15 | P68_20966046_ChIP-Seq_HELA_Human | 1.96011163 |
16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83938848 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83499768 |
18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.81112518 |
19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78448876 |
20 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.78361366 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77490551 |
22 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.76571315 |
23 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.75533303 |
24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.71445134 |
25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71076706 |
26 | ERA_21632823_ChIP-Seq_H3396_Human | 1.65145914 |
27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.60862494 |
28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.59601471 |
29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58509599 |
30 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.57374459 |
31 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.56997418 |
32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55873807 |
33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55529397 |
34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.54552897 |
35 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.54165011 |
36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53081262 |
37 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50966505 |
38 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49703350 |
39 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.45456732 |
40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44287736 |
41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42415306 |
42 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.41406408 |
43 | MAF_26560356_Chip-Seq_TH2_Human | 1.41292140 |
44 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.40288285 |
45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40228712 |
46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40228712 |
47 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.39532835 |
48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39107344 |
49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38654095 |
50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38514094 |
51 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.35716087 |
52 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34835038 |
53 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33827278 |
54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.33608443 |
55 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.33404934 |
56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30218868 |
57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29728571 |
58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28440152 |
59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.28273176 |
60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28259677 |
61 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.27998649 |
62 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.27588327 |
63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26967856 |
64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25258537 |
65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.23894092 |
66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23714981 |
67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23495028 |
68 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.22824904 |
69 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22404339 |
70 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.21368008 |
71 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.18908150 |
72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18721507 |
73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18408076 |
74 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18277042 |
75 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.18183875 |
76 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.17945697 |
77 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.17009052 |
78 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.16992215 |
79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16772799 |
80 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16652928 |
81 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15593828 |
82 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14862931 |
83 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13892420 |
84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13150022 |
85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12740618 |
86 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.12569559 |
87 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.12073290 |
88 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.11934328 |
89 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.11823223 |
90 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11770509 |
91 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11733223 |
92 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.11606616 |
93 | P300_27268052_Chip-Seq_Bcells_Human | 1.11082322 |
94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10982912 |
95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10804191 |
96 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.09633589 |
97 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09491105 |
98 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.08963489 |
99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08742078 |
100 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.06292939 |
101 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.06232936 |
102 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.05291249 |
103 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05180100 |
104 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05174379 |
105 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04984179 |
106 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04582718 |
107 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.04260009 |
108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03882561 |
109 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.03473478 |
110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03339452 |
111 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03144491 |
112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03059126 |
113 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02954211 |
114 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02749045 |
115 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02087387 |
116 | * MAF_26560356_Chip-Seq_TH1_Human | 1.00130965 |
117 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.99617931 |
118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99349427 |
119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99349427 |
120 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98521574 |
121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97438530 |
122 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96882089 |
123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.96720538 |
124 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95934482 |
125 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95342407 |
126 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93387937 |
127 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93234064 |
128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93142389 |
129 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92778661 |
130 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91819666 |
131 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90862309 |
132 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.89635903 |
133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88171808 |
134 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86646670 |
135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85869145 |
136 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.84989333 |
137 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84814151 |
138 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84802863 |
139 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84539372 |
140 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84326695 |
141 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83355114 |
142 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82807543 |
143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80480324 |
144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80480324 |
145 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78079342 |
146 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77746170 |
147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75084842 |
148 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.74714608 |
149 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.74609988 |
150 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73970115 |
151 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73777575 |
152 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73759432 |
153 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73613714 |
154 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73323083 |
155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.72794014 |
156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72730721 |
157 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.71954466 |
158 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.71858219 |
159 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.68873769 |
160 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.68095130 |
161 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.67804198 |
162 | AR_19668381_ChIP-Seq_PC3_Human | 0.67688030 |
163 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.67671873 |
164 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67527891 |
165 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65774904 |
166 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.65220997 |
167 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.64680495 |
168 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.64317114 |
169 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.64261244 |
170 | RXR_22108803_ChIP-Seq_LS180_Human | 0.64189231 |
171 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60275020 |
172 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60178702 |
173 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.59971926 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.84464584 |
2 | MP0005360_urolithiasis | 5.27038917 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.58000070 |
4 | MP0005365_abnormal_bile_salt | 4.44768976 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.09873105 |
6 | MP0001986_abnormal_taste_sensitivity | 3.98677938 |
7 | MP0005423_abnormal_somatic_nervous | 3.42722026 |
8 | MP0002837_dystrophic_cardiac_calcinosis | 3.33035205 |
9 | MP0005171_absent_coat_pigmentation | 3.23410530 |
10 | MP0005174_abnormal_tail_pigmentation | 3.14804180 |
11 | MP0001968_abnormal_touch/_nociception | 2.95659830 |
12 | MP0010329_abnormal_lipoprotein_level | 2.92013225 |
13 | MP0002822_catalepsy | 2.79939173 |
14 | MP0003252_abnormal_bile_duct | 2.65311438 |
15 | MP0009840_abnormal_foam_cell | 2.53271577 |
16 | MP0002638_abnormal_pupillary_reflex | 2.50411009 |
17 | MP0003806_abnormal_nucleotide_metabolis | 2.42822576 |
18 | MP0003136_yellow_coat_color | 2.37268377 |
19 | MP0005332_abnormal_amino_acid | 2.29486905 |
20 | MP0003195_calcinosis | 2.20003806 |
21 | MP0005083_abnormal_biliary_tract | 2.10473359 |
22 | MP0004885_abnormal_endolymph | 2.03020527 |
23 | MP0004130_abnormal_muscle_cell | 2.01954176 |
24 | MP0002735_abnormal_chemical_nociception | 1.99058326 |
25 | MP0002736_abnormal_nociception_after | 1.97904429 |
26 | MP0002118_abnormal_lipid_homeostasis | 1.91265254 |
27 | MP0003646_muscle_fatigue | 1.88606043 |
28 | MP0001666_abnormal_nutrient_absorption | 1.87778883 |
29 | MP0000751_myopathy | 1.83002030 |
30 | MP0004859_abnormal_synaptic_plasticity | 1.82708463 |
31 | MP0001485_abnormal_pinna_reflex | 1.82553516 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.64752708 |
33 | MP0002160_abnormal_reproductive_system | 1.63163519 |
34 | MP0004036_abnormal_muscle_relaxation | 1.61326978 |
35 | MP0005253_abnormal_eye_physiology | 1.59530407 |
36 | MP0004019_abnormal_vitamin_homeostasis | 1.57518149 |
37 | MP0002909_abnormal_adrenal_gland | 1.57058164 |
38 | MP0004142_abnormal_muscle_tone | 1.55221450 |
39 | MP0005670_abnormal_white_adipose | 1.54054038 |
40 | MP0005671_abnormal_response_to | 1.51501298 |
41 | MP0001188_hyperpigmentation | 1.49737052 |
42 | MP0004215_abnormal_myocardial_fiber | 1.48035009 |
43 | MP0001970_abnormal_pain_threshold | 1.46462077 |
44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45561696 |
45 | MP0000609_abnormal_liver_physiology | 1.44787402 |
46 | MP0004043_abnormal_pH_regulation | 1.42756072 |
47 | MP0003329_amyloid_beta_deposits | 1.41305062 |
48 | MP0004742_abnormal_vestibular_system | 1.36787096 |
49 | MP0005319_abnormal_enzyme/_coenzyme | 1.36231178 |
50 | MP0006292_abnormal_olfactory_placode | 1.33020624 |
51 | MP0001440_abnormal_grooming_behavior | 1.31787455 |
52 | MP0005535_abnormal_body_temperature | 1.28535263 |
53 | MP0006072_abnormal_retinal_apoptosis | 1.27351661 |
54 | MP0003868_abnormal_feces_composition | 1.26308043 |
55 | MP0003635_abnormal_synaptic_transmissio | 1.24902609 |
56 | MP0006036_abnormal_mitochondrial_physio | 1.24243844 |
57 | MP0005389_reproductive_system_phenotype | 1.23029495 |
58 | MP0005330_cardiomyopathy | 1.22982229 |
59 | MP0009780_abnormal_chondrocyte_physiolo | 1.22751928 |
60 | MP0003690_abnormal_glial_cell | 1.22093179 |
61 | MP0003787_abnormal_imprinting | 1.19697523 |
62 | MP0002733_abnormal_thermal_nociception | 1.19510471 |
63 | MP0008877_abnormal_DNA_methylation | 1.19084278 |
64 | MP0004084_abnormal_cardiac_muscle | 1.19082238 |
65 | MP0002090_abnormal_vision | 1.17477595 |
66 | MP0000015_abnormal_ear_pigmentation | 1.17167100 |
67 | MP0000749_muscle_degeneration | 1.16639898 |
68 | MP0004381_abnormal_hair_follicle | 1.16398810 |
69 | MP0005666_abnormal_adipose_tissue | 1.16238693 |
70 | MP0002067_abnormal_sensory_capabilities | 1.15514561 |
71 | MP0009745_abnormal_behavioral_response | 1.15438616 |
72 | MP0005167_abnormal_blood-brain_barrier | 1.14260921 |
73 | MP0002254_reproductive_system_inflammat | 1.13466988 |
74 | MP0002928_abnormal_bile_duct | 1.12941684 |
75 | MP0005410_abnormal_fertilization | 1.09338619 |
76 | MP0008961_abnormal_basal_metabolism | 1.08583302 |
77 | MP0002078_abnormal_glucose_homeostasis | 1.08249243 |
78 | MP0000604_amyloidosis | 1.08125119 |
79 | MP0009643_abnormal_urine_homeostasis | 1.07907929 |
80 | MP0004133_heterotaxia | 1.07116311 |
81 | MP0000013_abnormal_adipose_tissue | 1.06990825 |
82 | MP0002653_abnormal_ependyma_morphology | 1.06026632 |
83 | MP0002876_abnormal_thyroid_physiology | 1.05657379 |
84 | MP0000685_abnormal_immune_system | 1.03565603 |
85 | MP0005620_abnormal_muscle_contractility | 1.03372516 |
86 | MP0001919_abnormal_reproductive_system | 1.02559109 |
87 | MP0002971_abnormal_brown_adipose | 1.01744488 |
88 | MP0003878_abnormal_ear_physiology | 1.01708971 |
89 | MP0005377_hearing/vestibular/ear_phenot | 1.01708971 |
90 | MP0000538_abnormal_urinary_bladder | 1.01513920 |
91 | MP0002269_muscular_atrophy | 1.01070257 |
92 | MP0004924_abnormal_behavior | 0.99799601 |
93 | MP0005386_behavior/neurological_phenoty | 0.99799601 |
94 | MP0003011_delayed_dark_adaptation | 0.99524424 |
95 | MP0000750_abnormal_muscle_regeneration | 0.99371280 |
96 | MP0000569_abnormal_digit_pigmentation | 0.98901668 |
97 | MP0002138_abnormal_hepatobiliary_system | 0.97100953 |
98 | MP0003075_altered_response_to | 0.96639331 |
99 | * MP0002064_seizures | 0.96499492 |
100 | MP0004147_increased_porphyrin_level | 0.95593588 |
101 | MP0002063_abnormal_learning/memory/cond | 0.94888523 |
102 | MP0004145_abnormal_muscle_electrophysio | 0.94846040 |
103 | MP0000747_muscle_weakness | 0.94754878 |
104 | MP0008874_decreased_physiological_sensi | 0.94079151 |
105 | MP0000631_abnormal_neuroendocrine_gland | 0.93272759 |
106 | MP0003137_abnormal_impulse_conducting | 0.91976086 |
107 | MP0004087_abnormal_muscle_fiber | 0.91480682 |
108 | MP0001501_abnormal_sleep_pattern | 0.91051113 |
109 | MP0010368_abnormal_lymphatic_system | 0.90569395 |
110 | MP0001764_abnormal_homeostasis | 0.90389055 |
111 | MP0004270_analgesia | 0.89065955 |
112 | MP0005646_abnormal_pituitary_gland | 0.88668391 |
113 | MP0000230_abnormal_systemic_arterial | 0.88023804 |
114 | MP0002557_abnormal_social/conspecific_i | 0.87788798 |
115 | MP0003633_abnormal_nervous_system | 0.86744239 |
116 | MP0004085_abnormal_heartbeat | 0.86015877 |
117 | MP0001963_abnormal_hearing_physiology | 0.85993374 |
118 | MP0001800_abnormal_humoral_immune | 0.84992181 |
119 | MP0003705_abnormal_hypodermis_morpholog | 0.84227968 |
120 | MP0009046_muscle_twitch | 0.82744988 |
121 | MP0002163_abnormal_gland_morphology | 0.82208035 |
122 | MP0005375_adipose_tissue_phenotype | 0.82022820 |
123 | MP0002972_abnormal_cardiac_muscle | 0.81755778 |
124 | MP0000026_abnormal_inner_ear | 0.81681280 |
125 | MP0005334_abnormal_fat_pad | 0.79794312 |
126 | MP0002734_abnormal_mechanical_nocicepti | 0.78478430 |
127 | MP0008569_lethality_at_weaning | 0.77549683 |
128 | MP0001486_abnormal_startle_reflex | 0.76901678 |
129 | MP0002229_neurodegeneration | 0.76578804 |
130 | MP0004185_abnormal_adipocyte_glucose | 0.76330186 |
131 | MP0002095_abnormal_skin_pigmentation | 0.75707964 |
132 | MP0005645_abnormal_hypothalamus_physiol | 0.75165234 |
133 | * MP0002272_abnormal_nervous_system | 0.74897647 |
134 | MP0005551_abnormal_eye_electrophysiolog | 0.74417952 |
135 | MP0002572_abnormal_emotion/affect_behav | 0.74347707 |
136 | MP0002752_abnormal_somatic_nervous | 0.73645115 |
137 | MP0002933_joint_inflammation | 0.73542043 |
138 | MP0000372_irregular_coat_pigmentation | 0.73237402 |
139 | MP0002723_abnormal_immune_serum | 0.73171503 |
140 | MP0001544_abnormal_cardiovascular_syste | 0.72847510 |
141 | MP0005385_cardiovascular_system_phenoty | 0.72847510 |
142 | MP0005448_abnormal_energy_balance | 0.72432445 |
143 | MP0006276_abnormal_autonomic_nervous | 0.72218250 |
144 | MP0005636_abnormal_mineral_homeostasis | 0.71944760 |
145 | MP0005075_abnormal_melanosome_morpholog | 0.71915737 |
146 | MP0009764_decreased_sensitivity_to | 0.71835654 |
147 | MP0002332_abnormal_exercise_endurance | 0.71624018 |
148 | MP0001765_abnormal_ion_homeostasis | 0.71534863 |
149 | MP0008872_abnormal_physiological_respon | 0.71519507 |
150 | MP0006138_congestive_heart_failure | 0.71237960 |
151 | MP0001324_abnormal_eye_pigmentation | 0.70706947 |
152 | MP0005647_abnormal_sex_gland | 0.70223867 |
153 | MP0002882_abnormal_neuron_morphology | 0.69918227 |
154 | MP0001756_abnormal_urination | 0.69555404 |
155 | MP0005195_abnormal_posterior_eye | 0.69486113 |
156 | MP0009642_abnormal_blood_homeostasis | 0.69228055 |
157 | MP0008775_abnormal_heart_ventricle | 0.68758954 |
158 | MP0003638_abnormal_response/metabolism_ | 0.67153813 |
159 | MP0003880_abnormal_central_pattern | 0.67136820 |
160 | MP0000470_abnormal_stomach_morphology | 0.65529836 |
161 | MP0003879_abnormal_hair_cell | 0.65083518 |
162 | MP0005266_abnormal_metabolism | 0.64809735 |
163 | * MP0001502_abnormal_circadian_rhythm | 0.63438689 |
164 | MP0004484_altered_response_of | 0.63436699 |
165 | MP0003656_abnormal_erythrocyte_physiolo | 0.61952367 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.32446706 |
2 | Deep venous thrombosis (HP:0002625) | 4.90850037 |
3 | Xanthomatosis (HP:0000991) | 4.66158625 |
4 | Intrahepatic cholestasis (HP:0001406) | 4.58021466 |
5 | Ketosis (HP:0001946) | 4.37141143 |
6 | Hyperlipoproteinemia (HP:0010980) | 4.28305755 |
7 | Congenital stationary night blindness (HP:0007642) | 4.26253441 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.07817719 |
9 | Attenuation of retinal blood vessels (HP:0007843) | 4.04049797 |
10 | Prolonged partial thromboplastin time (HP:0003645) | 4.03614418 |
11 | Ketoacidosis (HP:0001993) | 3.90139128 |
12 | Decreased circulating renin level (HP:0003351) | 3.81850468 |
13 | Hyperammonemia (HP:0001987) | 3.81786915 |
14 | Hypoglycemic coma (HP:0001325) | 3.78045175 |
15 | Hyperglycinuria (HP:0003108) | 3.73290556 |
16 | Hypobetalipoproteinemia (HP:0003563) | 3.72952616 |
17 | Rib fusion (HP:0000902) | 3.71661939 |
18 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.70991113 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 3.52397064 |
20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.51764518 |
21 | Abnormality of glycine metabolism (HP:0010895) | 3.51764518 |
22 | Hypoplasia of the pons (HP:0012110) | 3.45343661 |
23 | Complement deficiency (HP:0004431) | 3.45177326 |
24 | Hyperglycinemia (HP:0002154) | 3.38889591 |
25 | Hypolipoproteinemia (HP:0010981) | 3.35856674 |
26 | Exercise-induced myalgia (HP:0003738) | 3.34025554 |
27 | Type II lissencephaly (HP:0007260) | 3.18932177 |
28 | Myoglobinuria (HP:0002913) | 3.18274505 |
29 | Abolished electroretinogram (ERG) (HP:0000550) | 3.14006217 |
30 | Abnormality of the pons (HP:0007361) | 3.13221609 |
31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.13132654 |
32 | Anomalous pulmonary venous return (HP:0010772) | 3.13054549 |
33 | Pendular nystagmus (HP:0012043) | 3.11568369 |
34 | Decreased central vision (HP:0007663) | 3.10634323 |
35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04636259 |
36 | Gout (HP:0001997) | 3.01293738 |
37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.00702693 |
38 | Epidermoid cyst (HP:0200040) | 2.99563493 |
39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.96143091 |
40 | Delayed CNS myelination (HP:0002188) | 2.93735203 |
41 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.89307163 |
42 | Pancreatic cysts (HP:0001737) | 2.81549836 |
43 | Polydipsia (HP:0001959) | 2.80276685 |
44 | Abnormal drinking behavior (HP:0030082) | 2.80276685 |
45 | Chorioretinal atrophy (HP:0000533) | 2.80236352 |
46 | Hypercholesterolemia (HP:0003124) | 2.78706706 |
47 | Congenital sensorineural hearing impairment (HP:0008527) | 2.77175876 |
48 | Genetic anticipation (HP:0003743) | 2.75845677 |
49 | Cerebellar dysplasia (HP:0007033) | 2.75332015 |
50 | Abnormality of the pulmonary veins (HP:0011718) | 2.72867352 |
51 | Sudden death (HP:0001699) | 2.70072128 |
52 | Abnormality of the common coagulation pathway (HP:0010990) | 2.68377591 |
53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66958119 |
54 | Abnormality of midbrain morphology (HP:0002418) | 2.62868291 |
55 | Molar tooth sign on MRI (HP:0002419) | 2.62868291 |
56 | Dicarboxylic aciduria (HP:0003215) | 2.62219544 |
57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62219544 |
58 | Hepatocellular necrosis (HP:0001404) | 2.60484988 |
59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.57480462 |
60 | Skin nodule (HP:0200036) | 2.56962918 |
61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.56065280 |
62 | Joint hemorrhage (HP:0005261) | 2.54546860 |
63 | Late onset (HP:0003584) | 2.54095345 |
64 | Metabolic acidosis (HP:0001942) | 2.52799718 |
65 | Pancreatic fibrosis (HP:0100732) | 2.52532017 |
66 | Progressive cerebellar ataxia (HP:0002073) | 2.52495404 |
67 | Lipid accumulation in hepatocytes (HP:0006561) | 2.52059697 |
68 | Cholelithiasis (HP:0001081) | 2.51411430 |
69 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.50794551 |
70 | Nephronophthisis (HP:0000090) | 2.50324204 |
71 | Abnormality of methionine metabolism (HP:0010901) | 2.50307595 |
72 | Abnormality of the intrinsic pathway (HP:0010989) | 2.47798261 |
73 | Abnormal gallbladder morphology (HP:0012437) | 2.46586996 |
74 | Exercise-induced muscle cramps (HP:0003710) | 2.46166342 |
75 | Atrioventricular block (HP:0001678) | 2.45059914 |
76 | Hemiplegia (HP:0002301) | 2.43973043 |
77 | Mitochondrial inheritance (HP:0001427) | 2.43333600 |
78 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.41843506 |
79 | Renal Fanconi syndrome (HP:0001994) | 2.41284393 |
80 | True hermaphroditism (HP:0010459) | 2.39987939 |
81 | Hypoglycemic seizures (HP:0002173) | 2.39865339 |
82 | Hyperbilirubinemia (HP:0002904) | 2.39397077 |
83 | Status epilepticus (HP:0002133) | 2.37778938 |
84 | Abnormality of purine metabolism (HP:0004352) | 2.37279578 |
85 | Fat malabsorption (HP:0002630) | 2.37125471 |
86 | Tubular atrophy (HP:0000092) | 2.36453485 |
87 | Abnormal number of erythroid precursors (HP:0012131) | 2.36109710 |
88 | Cerebral edema (HP:0002181) | 2.34845614 |
89 | Squamous cell carcinoma (HP:0002860) | 2.34265021 |
90 | Calf muscle hypertrophy (HP:0008981) | 2.34168451 |
91 | Facial diplegia (HP:0001349) | 2.33970101 |
92 | Abnormal gallbladder physiology (HP:0012438) | 2.30422138 |
93 | Cholecystitis (HP:0001082) | 2.30422138 |
94 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.28930572 |
95 | Hypoalbuminemia (HP:0003073) | 2.26261037 |
96 | Abnormal albumin level (HP:0012116) | 2.26261037 |
97 | Lethargy (HP:0001254) | 2.24897728 |
98 | Heart block (HP:0012722) | 2.23645195 |
99 | Right ventricular cardiomyopathy (HP:0011663) | 2.23476608 |
100 | Abnormality of DNA repair (HP:0003254) | 2.22928645 |
101 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.22647929 |
102 | Increased hepatocellular lipid droplets (HP:0006565) | 2.22539142 |
103 | Premature graying of hair (HP:0002216) | 2.22449588 |
104 | Abnormality of complement system (HP:0005339) | 2.21789904 |
105 | Febrile seizures (HP:0002373) | 2.21048552 |
106 | Patellar aplasia (HP:0006443) | 2.19549156 |
107 | Abnormality of serum amino acid levels (HP:0003112) | 2.19448389 |
108 | Asplenia (HP:0001746) | 2.19290849 |
109 | Focal motor seizures (HP:0011153) | 2.19096050 |
110 | Sensorimotor neuropathy (HP:0007141) | 2.16781880 |
111 | Mesangial abnormality (HP:0001966) | 2.15605888 |
112 | Increased muscle lipid content (HP:0009058) | 2.14753837 |
113 | Polyuria (HP:0000103) | 2.14151785 |
114 | Annular pancreas (HP:0001734) | 2.12748947 |
115 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.12528195 |
116 | Akinesia (HP:0002304) | 2.11975245 |
117 | Increased CSF lactate (HP:0002490) | 2.11788023 |
118 | Myotonia (HP:0002486) | 2.11608475 |
119 | 3-Methylglutaconic aciduria (HP:0003535) | 2.11439023 |
120 | Neonatal onset (HP:0003623) | 2.10638140 |
121 | Palpitations (HP:0001962) | 2.10435606 |
122 | Asymmetric septal hypertrophy (HP:0001670) | 2.09588222 |
123 | Myokymia (HP:0002411) | 2.09495067 |
124 | Oral leukoplakia (HP:0002745) | 2.09449894 |
125 | Conjugated hyperbilirubinemia (HP:0002908) | 2.09193770 |
126 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.09148475 |
127 | Clumsiness (HP:0002312) | 2.08588475 |
128 | Abnormality of renin-angiotensin system (HP:0000847) | 2.08457395 |
129 | Chronic hepatic failure (HP:0100626) | 2.08285783 |
130 | Bundle branch block (HP:0011710) | 2.08075331 |
131 | Generalized aminoaciduria (HP:0002909) | 2.07554554 |
132 | Hepatic necrosis (HP:0002605) | 2.07123772 |
133 | Amyloidosis (HP:0011034) | 2.06077558 |
134 | Abnormal atrioventricular conduction (HP:0005150) | 2.05791899 |
135 | Poikiloderma (HP:0001029) | 2.05469178 |
136 | Abnormality of the renal medulla (HP:0100957) | 2.04321712 |
137 | Absent thumb (HP:0009777) | 2.03889701 |
138 | Syncope (HP:0001279) | 2.03819334 |
139 | Rectovaginal fistula (HP:0000143) | 2.03599425 |
140 | Rectal fistula (HP:0100590) | 2.03599425 |
141 | Hyporeflexia of lower limbs (HP:0002600) | 2.01906127 |
142 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01455807 |
143 | Increased intramyocellular lipid droplets (HP:0012240) | 2.01327819 |
144 | Vomiting (HP:0002013) | 2.00026414 |
145 | Abnormality of nucleobase metabolism (HP:0010932) | 1.99562145 |
146 | Severe muscular hypotonia (HP:0006829) | 1.99049580 |
147 | Vertebral fusion (HP:0002948) | 1.98380730 |
148 | Abnormality of the renal cortex (HP:0011035) | 1.98123301 |
149 | Epileptic encephalopathy (HP:0200134) | 1.98029538 |
150 | Neurofibrillary tangles (HP:0002185) | 1.96649779 |
151 | Abnormality of binocular vision (HP:0011514) | 1.94575785 |
152 | Diplopia (HP:0000651) | 1.94575785 |
153 | Impaired smooth pursuit (HP:0007772) | 1.93307126 |
154 | Confusion (HP:0001289) | 1.91555129 |
155 | Ventricular tachycardia (HP:0004756) | 1.90824777 |
156 | Irritability (HP:0000737) | 1.90532690 |
157 | Rhabdomyolysis (HP:0003201) | 1.90346042 |
158 | Hypokalemic alkalosis (HP:0001949) | 1.88786104 |
159 | Hyperuricemia (HP:0002149) | 1.87408256 |
160 | Increased purine levels (HP:0004368) | 1.87408256 |
161 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.86892228 |
162 | Hyperglycemia (HP:0003074) | 1.85309368 |
163 | Methylmalonic aciduria (HP:0012120) | 1.84183552 |
164 | Intestinal fistula (HP:0100819) | 1.83169128 |
165 | Abnormality of the Achilles tendon (HP:0005109) | 1.83087162 |
166 | Visual hallucinations (HP:0002367) | 1.83001783 |
167 | Gaze-evoked nystagmus (HP:0000640) | 1.82538018 |
168 | Severe visual impairment (HP:0001141) | 1.81987645 |
169 | Torticollis (HP:0000473) | 1.81632070 |
170 | Hyperventilation (HP:0002883) | 1.81531114 |
171 | Macular degeneration (HP:0000608) | 1.80616280 |
172 | Ventricular fibrillation (HP:0001663) | 1.80212813 |
173 | Prolonged QT interval (HP:0001657) | 1.80170228 |
174 | Hyperkalemia (HP:0002153) | 1.80089232 |
175 | Abnormality of the gallbladder (HP:0005264) | 1.79864377 |
176 | Hydroxyprolinuria (HP:0003080) | 1.78716307 |
177 | Abnormality of proline metabolism (HP:0010907) | 1.78716307 |
178 | Abnormal urine output (HP:0012590) | 1.78695648 |
179 | Anxiety (HP:0000739) | 1.78472973 |
180 | Mitral stenosis (HP:0001718) | 1.77971645 |
181 | Small hand (HP:0200055) | 1.77888820 |
182 | Atrial fibrillation (HP:0005110) | 1.77204264 |
183 | Cystic liver disease (HP:0006706) | 1.76824141 |
184 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76646596 |
185 | Dysmetric saccades (HP:0000641) | 1.76337589 |
186 | Vascular calcification (HP:0004934) | 1.76151080 |
187 | Ventricular arrhythmia (HP:0004308) | 1.76132508 |
188 | Difficulty running (HP:0009046) | 1.75143132 |
189 | Testicular atrophy (HP:0000029) | 1.74659446 |
190 | IgG deficiency (HP:0004315) | 1.74080478 |
191 | Polycythemia (HP:0001901) | 1.74072088 |
192 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.73235749 |
193 | Brushfield spots (HP:0001088) | 1.73064861 |
194 | Abnormality of renal resorption (HP:0011038) | 1.71302004 |
195 | Absent speech (HP:0001344) | 1.70336384 |
196 | Medial flaring of the eyebrow (HP:0010747) | 1.67090486 |
197 | Methylmalonic acidemia (HP:0002912) | 1.66600874 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TLK1 | 4.59084784 |
2 | EPHA4 | 4.15549597 |
3 | BCKDK | 3.96379760 |
4 | FRK | 2.97800804 |
5 | ADRBK2 | 2.89812428 |
6 | ZAK | 2.85237955 |
7 | PINK1 | 2.41871723 |
8 | TRIB3 | 2.41013487 |
9 | SIK1 | 2.33324440 |
10 | INSRR | 2.24028016 |
11 | PHKG1 | 2.17830931 |
12 | PHKG2 | 2.17830931 |
13 | TTN | 2.15814952 |
14 | ACVR1B | 2.13604977 |
15 | LMTK2 | 2.09593158 |
16 | DAPK2 | 2.04088501 |
17 | MAP2K4 | 2.03498812 |
18 | ERN1 | 1.93865694 |
19 | BLK | 1.89094822 |
20 | GRK1 | 1.87559827 |
21 | TXK | 1.82088387 |
22 | GRK6 | 1.74608912 |
23 | NTRK3 | 1.70338297 |
24 | SIK2 | 1.69212657 |
25 | RIPK1 | 1.67207662 |
26 | MAP4K1 | 1.66520322 |
27 | STK16 | 1.64875698 |
28 | MAP3K9 | 1.57278740 |
29 | KSR2 | 1.52971017 |
30 | PKN2 | 1.50217992 |
31 | BMPR1B | 1.49330335 |
32 | OBSCN | 1.45297216 |
33 | IKBKB | 1.44068988 |
34 | WNK4 | 1.43070586 |
35 | MAP3K7 | 1.40822058 |
36 | MAP3K4 | 1.36670851 |
37 | NUAK1 | 1.36041128 |
38 | MYLK | 1.35941015 |
39 | PDK4 | 1.33688876 |
40 | PDK3 | 1.33688876 |
41 | FGFR4 | 1.33615343 |
42 | PRKD3 | 1.28611993 |
43 | TAF1 | 1.27087072 |
44 | MAP2K6 | 1.26331971 |
45 | ADRBK1 | 1.24524759 |
46 | CAMKK1 | 1.24341931 |
47 | MAP3K13 | 1.24252468 |
48 | PAK6 | 1.21648527 |
49 | NTRK1 | 1.20215344 |
50 | GRK7 | 1.18179449 |
51 | STK38 | 1.17964205 |
52 | MAPKAPK3 | 1.17178211 |
53 | CDK19 | 1.14252778 |
54 | TNK2 | 1.11443089 |
55 | MAPK12 | 1.10645613 |
56 | MAPK13 | 1.09546973 |
57 | MAP3K2 | 1.09156795 |
58 | VRK1 | 1.08880182 |
59 | MAP2K2 | 1.05319016 |
60 | MARK3 | 1.02727910 |
61 | OXSR1 | 1.01017131 |
62 | RPS6KA6 | 1.00771677 |
63 | PDPK1 | 0.99508680 |
64 | VRK2 | 0.98229961 |
65 | FGFR2 | 0.97608601 |
66 | TIE1 | 0.96938286 |
67 | PIM2 | 0.93617889 |
68 | PIM1 | 0.93416258 |
69 | PRKAA2 | 0.92625603 |
70 | SGK3 | 0.92427118 |
71 | MAPK15 | 0.89136313 |
72 | PIK3CG | 0.89071393 |
73 | NTRK2 | 0.88920764 |
74 | NEK1 | 0.88916613 |
75 | PRKCQ | 0.88664133 |
76 | PAK3 | 0.88570914 |
77 | MAPKAPK5 | 0.88277415 |
78 | MUSK | 0.87166988 |
79 | DMPK | 0.84397251 |
80 | CAMK1 | 0.83456526 |
81 | SGK223 | 0.83213647 |
82 | SGK494 | 0.83213647 |
83 | MAP3K11 | 0.81252785 |
84 | PRKCH | 0.81206638 |
85 | RPS6KA5 | 0.80874443 |
86 | CAMK1G | 0.79912550 |
87 | TAOK1 | 0.79045492 |
88 | MAP3K1 | 0.78964900 |
89 | AKT3 | 0.78547980 |
90 | SGK2 | 0.78481418 |
91 | MINK1 | 0.77586810 |
92 | PRKD1 | 0.77520312 |
93 | PDK2 | 0.77425993 |
94 | CDK5 | 0.76832253 |
95 | PDK1 | 0.76628737 |
96 | WNK1 | 0.76607054 |
97 | RPS6KC1 | 0.75620473 |
98 | RPS6KL1 | 0.75620473 |
99 | SYK | 0.75128225 |
100 | IKBKE | 0.74784807 |
101 | HIPK2 | 0.74316272 |
102 | CAMKK2 | 0.73928959 |
103 | CAMK2G | 0.73183474 |
104 | CAMK1D | 0.72938352 |
105 | RET | 0.72198200 |
106 | MAP4K2 | 0.71043997 |
107 | CASK | 0.70453221 |
108 | PTK6 | 0.68835786 |
109 | ARAF | 0.67875070 |
110 | MAP2K7 | 0.67424523 |
111 | MAPK11 | 0.67315171 |
112 | MST1R | 0.66980966 |
113 | TBK1 | 0.66925983 |
114 | PKN1 | 0.66802133 |
115 | PRKAA1 | 0.66390653 |
116 | MAP2K1 | 0.65371754 |
117 | STK39 | 0.65090417 |
118 | PTK2B | 0.64695057 |
119 | TAOK3 | 0.64629220 |
120 | PRKACG | 0.64465705 |
121 | CAMK4 | 0.64321323 |
122 | CAMK2D | 0.63713199 |
123 | PDGFRA | 0.63653076 |
124 | CAMK2A | 0.63448528 |
125 | JAK2 | 0.62706097 |
126 | PRKCI | 0.61454269 |
127 | PRKCZ | 0.59386239 |
128 | PRKCG | 0.59030335 |
129 | FLT3 | 0.56500141 |
130 | PIK3CA | 0.56009605 |
131 | MAP2K3 | 0.55764224 |
132 | RPS6KA2 | 0.54775330 |
133 | ABL2 | 0.53601505 |
134 | FER | 0.53126225 |
135 | MARK2 | 0.52794492 |
136 | RIPK4 | 0.51376434 |
137 | MAP3K3 | 0.50815933 |
138 | SGK1 | 0.50264238 |
139 | LYN | 0.49667057 |
140 | PRKD2 | 0.48983236 |
141 | TNIK | 0.47508362 |
142 | GRK5 | 0.45899892 |
143 | FES | 0.45710567 |
144 | PRKACA | 0.45516823 |
145 | TYRO3 | 0.45211245 |
146 | CDC42BPA | 0.44743800 |
147 | JAK1 | 0.44654409 |
148 | TGFBR2 | 0.44425606 |
149 | DAPK3 | 0.43561521 |
150 | RPS6KA3 | 0.42717233 |
151 | MAPK7 | 0.42694648 |
152 | DYRK3 | 0.42694391 |
153 | STK11 | 0.42639463 |
154 | AURKA | 0.42345475 |
155 | CSNK1G3 | 0.41427776 |
156 | CSNK1G2 | 0.41085184 |
157 | CSNK1A1L | 0.41024173 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70539739 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.24155226 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.22683825 |
4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.87592431 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72494226 |
6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.69275165 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60667417 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.53365730 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35356824 |
10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31536275 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.26191461 |
12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.24766633 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20755496 |
14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.19556884 |
15 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.17262418 |
16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16216082 |
17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.15729500 |
18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09442896 |
19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.08250485 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98974191 |
21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.98608990 |
22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.93752145 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88947238 |
24 | Phototransduction_Homo sapiens_hsa04744 | 1.88426268 |
25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.72056928 |
26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.71546075 |
27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.69479634 |
28 | Alcoholism_Homo sapiens_hsa05034 | 1.67993491 |
29 | Bile secretion_Homo sapiens_hsa04976 | 1.65218182 |
30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64636590 |
31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64545218 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64388112 |
33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63858239 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.62539346 |
35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.59770029 |
36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59258333 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59246201 |
38 | Taste transduction_Homo sapiens_hsa04742 | 1.57969820 |
39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57524421 |
40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.55528491 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46301300 |
42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44129182 |
43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41980628 |
44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.38246793 |
45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37214403 |
46 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34073273 |
47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33073553 |
48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31832565 |
49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31380219 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27172386 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26860697 |
52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.26064542 |
53 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22131696 |
54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.15910790 |
55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10333959 |
56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09928160 |
57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08572593 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07388520 |
59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05103672 |
60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04870895 |
61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.04782322 |
62 | ABC transporters_Homo sapiens_hsa02010 | 1.04093745 |
63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.03492119 |
64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03427337 |
65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96951007 |
66 | RNA polymerase_Homo sapiens_hsa03020 | 0.94436843 |
67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93755653 |
68 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.93256025 |
69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93064553 |
70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87942962 |
71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87729392 |
72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87612168 |
73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.87037897 |
74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85547681 |
75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84932379 |
76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84917216 |
77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84634648 |
78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83088919 |
79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82433802 |
80 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80313606 |
81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.79443189 |
82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76729682 |
83 | Mineral absorption_Homo sapiens_hsa04978 | 0.74175854 |
84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73727966 |
85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73719655 |
86 | Ribosome_Homo sapiens_hsa03010 | 0.71749659 |
87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71315507 |
88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70777089 |
89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69192991 |
90 | Asthma_Homo sapiens_hsa05310 | 0.68844342 |
91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67000226 |
92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66902749 |
93 | Insulin secretion_Homo sapiens_hsa04911 | 0.66054520 |
94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65365411 |
95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63374742 |
96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61953273 |
97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61456850 |
98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59774797 |
99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59404968 |
100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58332814 |
101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57477989 |
102 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57058912 |
103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56822168 |
104 | Lysine degradation_Homo sapiens_hsa00310 | 0.56434806 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55517981 |
106 | Lysosome_Homo sapiens_hsa04142 | 0.54919025 |
107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.54691997 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.54552290 |
109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54103597 |
110 | Salivary secretion_Homo sapiens_hsa04970 | 0.53619432 |
111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53343604 |
112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53256310 |
113 | Homologous recombination_Homo sapiens_hsa03440 | 0.52838942 |
114 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51491339 |
115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51406895 |
116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50655222 |
117 | Renin secretion_Homo sapiens_hsa04924 | 0.50338903 |
118 | Allograft rejection_Homo sapiens_hsa05330 | 0.48400090 |
119 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48314017 |
120 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47577735 |
121 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47335074 |
122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47097864 |
123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46288230 |
124 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46237181 |
125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46146092 |
126 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45978063 |
127 | Nicotine addiction_Homo sapiens_hsa05033 | 0.45738097 |
128 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45652428 |
129 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45625444 |
130 | Morphine addiction_Homo sapiens_hsa05032 | 0.43807227 |
131 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43111441 |
132 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42150952 |
133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40410749 |
134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40251161 |
135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39854195 |
136 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38435715 |
137 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38278563 |
138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37859789 |
139 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37502688 |
140 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37431496 |
141 | Basal transcription factors_Homo sapiens_hsa03022 | 0.36838583 |
142 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36506446 |
143 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36052844 |
144 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35663784 |
145 | Prion diseases_Homo sapiens_hsa05020 | 0.35515678 |
146 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35011817 |
147 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33641089 |
148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33582490 |
149 | Long-term potentiation_Homo sapiens_hsa04720 | 0.31895501 |
150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31163488 |
151 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31064038 |
152 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.30882107 |
153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30615009 |
154 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30158184 |
155 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29251878 |
156 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29183227 |
157 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27937898 |